COVID-19 vaccine effective in cancer patients
The Moderna and Pfizer BioNTech vaccines prevented COVID-19 infection in cancer patients, particularly in those whose treatment concluded more than six months before vaccination, say researchers at Stanford, Harvard and the VA.
Piecemeal e-cigarette policies bad for youth
Flavored disposable e-cigarettes attractive to young users proliferated after the most recent round of FDA policy announcements, negating the policies’ intended effects, a Stanford study found.
Smartwatch stress alerts
Stanford Medicine researchers created an algorithm to notify smartwatch wearers of stress, capturing events such as air travel, extended exercise and illness.
Experts: Pandemic sparked key innovations
In the final installment of The Pandemic Puzzle: Lessons from COVID-19, leaders in government, academia, health care and business said biomedical and digital health advances of the last few years will help combat future health crises.
Researchers to study long COVID
Data suggest that between 10% and 30% of those who have had an acute SARS-CoV-2 infection will experience the persistent pattern of symptoms known as long COVID.
Pathology faculty net four NIH grants
Efforts to design a hepatitis C vaccine, understand the genetic causes of rare diseases, map genetic regulatory elements in organ systems and understand coronavirus immune responses garner over $40 million.
Grants for genome research
Five Stanford researchers will participate in a $180 million nationwide campaign by the National Institutes of Health to understand the effect of human-genome variations on health and disease.
Common genetic profile linked to drug reaction
New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.
Climate change and health
The director of the Center for Innovation in Global Health explains how the medical community is at the center of the climate change debate.
New immunotherapy targets tumors
Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in laboratory mice after it’s injected into their bloodstreams.